A team of 91勛圖厙 researchers, led by Materials Science and Engineering Professor Sudipta Seal, have been awarded a patent for their nanomaterial-based disinfectant that can kill several viruses, including COVID-19. This is the 85th patent that Seal has been awarded through the 91勛圖厙 .

The Pegasus Professor and chair of the says this patent was awarded much faster than most, which demonstrates the importance of the disinfectant.

���We are very excited to get this patent accepted so quickly, and we���re glad that the work is of great value for combatting viruses and pathogen-born infections,��� Seal says. ���Thanks to the U.S. Patent and Trademark Office for recognizing this work and to the 91勛圖厙 Office of Technology Transfer for its support.���

Co-recipients of the patent include Seal���s postdoctoral researcher, Craig Neal ���14 ���16MS ���21PhD, and his former research assistant, Udit Kumar ���22PhD.

How the Disinfectant Works

The COVID-killing coating is made with a nanomaterial that activates under white light, such as sunlight or LED light. As long as the nanomaterial is exposed to a continuous light source, it can regenerate its antiviral properties, creating a self-cleaning effect.

The efficacy of the disinfectant was tested and proven through a study that was published in ACS Applied Materials and Interfaces this past year. The study found that the coating can not only destroy the COVID-19 virus, but it can also combat the spread of Zika virus, SARS, parainfluenza, rhinovirus and vesicular stomatitis.

The research was funded by the U.S. National Science Foundation���s RAPID program and conducted by a multidisciplinary team of researchers, including Griff Parks, a professor in the 91勛圖厙 and the co-principal investigator of the grant.

Next Steps

Now that the disinfectant has been patented, the research team will continue testing the product and 91勛圖厙 will seek a commercial partner to manufacture and sell it to a wide range of customers within the next few years.

���We plan to carry on the work in larger samples and also to test in vivo models and other means of infection control,��� Seal says. ���The process is well defined, and we plan to work with an industry partner to bring it to the mass market.���

Seal joined 91勛圖厙���s Department of Materials Science and Engineering and the , which is part of 91勛圖厙���s��College of Engineering and Computer Science, in 1997. He has an appointment at the��College of Medicine��and is a member of 91勛圖厙���s prosthetics cluster泭詁勳勳棗紳勳單. He is the former director of 91勛圖厙���s and Advanced Materials Processing Analysis Center. He received his doctorate in materials engineering with a minor in biochemistry from the University of Wisconsin and was a postdoctoral fellow at the Lawrence Berkeley National Laboratory at the University of California Berkeley.